Skip to content

Essential Facts That Men Diagnosed with Prostate Cancer Need to Understand

Groundbreaking research reveals optimal methods for managing low-risk malignancies. Conventional treatments such as radiation and surgery may not yield the best results.

Essential Information for Men Facing Prostate Cancer Diagnosis
Essential Information for Men Facing Prostate Cancer Diagnosis

Essential Facts That Men Diagnosed with Prostate Cancer Need to Understand

Prostate cancer is a common diagnosis for men over 50, with approximately 70,000 cases reported each year. One of the ongoing debates in the medical community is the best treatment approach for low-risk prostate cancers, a question that the British ProtecT study aims to answer.

The British ProtecT study, led by researchers, has been investigating the most effective treatment options for low-risk prostate cancers: surgery, radiation, or active surveillance. After fifteen years of follow-up, long-term data on survival rates and side effects have been published.

The study's results revealed no significant difference in prostate cancer-specific survival among the three treatment methods. However, side effects varied notably. Surgery, for instance, was found to cause higher rates of urinary incontinence and erectile dysfunction. Radiotherapy, on the other hand, was linked to bowel problems. Active monitoring, while associated with fewer immediate side effects, carries a risk of cancer progression.

Professor Peter Albers, the director of the Urology Clinic at Düsseldorf University Hospital, explains the implications of these findings for treatment. He emphasises the importance of considering each patient's individual circumstances and preferences when making treatment decisions.

While the original price for access to all FAZ+ articles is €12.80, the study's findings are widely available and accessible to all, providing valuable insights for both patients and healthcare professionals. The British ProtecT study continues to contribute significantly to our understanding of prostate cancer and its treatment, offering hope for improved outcomes and quality of life for those affected by this disease.

Read also:

Latest